Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy

Update Il y a 5 ans
Reference: NCT00464776

Woman and Man

  • | Country :
  • Denmark
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study will assess the optimal renoprotective dose of Aliskiren in hypertensive type 2 diabetes patients with incipient or overt nephropathy


Inclusion criteria

  • Diabetes Mellitus, Type 2

Links